About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 238 record(s)
Req # A-2023-36126
When referring to page numbers below, I mean the pages in the Client Package disclosed under A-2022-05111. Specifically, I would like to request the following: 1. The "Board deck" (presumably a PowerPoint presentation) mentioned on pages…Organization: Patented Medicine Prices Review Board Canada
September 2023
Req # A-2022-05111
Electronic copies of the following documents. In all cases, cabinet confidences may be excluded and draft versions of documents. In all of the requests below, “draft guidelines” refers to the PMPRB Guidelines that were published for comment on…Organization: Patented Medicine Prices Review Board Canada
July 2023
Req # A-2023-025211
With regard to the c. 2003 HDAP Report on New Patented Drug - Angiomax (http://www.pmprbcepmb.gc.ca/view.asp?ccid=583), I am looking for a copy of any supporting research, reports and calculations used to determine dosage regimens. I am specifically…Organization: Patented Medicine Prices Review Board Canada
July 2023
Req # A-2023-025599
For FY 2015-2022 (inclusive), how many investigations into prescription pricing on the basis that the pricing exceeded the guidelines resulted in a public hearing? Of those that resulted in a public hearing, in how many was the pricing found to be…Organization: Patented Medicine Prices Review Board Canada
July 2023
Req # A-2023-025896
For fiscal years 2015-2022 (inclusive), how many new patented medicines were reported to the board by Bayer, Inc.? From among those reports, how many included claims that a price exceeded the guidelines?Organization: Patented Medicine Prices Review Board Canada
July 2023
Req # A-2023-025600
For FY 2015-2022 (inclusive), how many Advance Certificate Rulings were issued by the board?Organization: Patented Medicine Prices Review Board Canada
July 2023
Req # A 2022_0011
All discussion of the processing / other work done on these ATIP requests: A-2022-0010, A-2022-0009, A-2022-0008, A-2022-0007Organization: Canada Development Investment Corporation
April 2023
Req # A 2022_0013
All communications exchanged between employees of CDEV and representatives of Volkswagen from March 1st, 2022, to date of receipt of requestOrganization: Canada Development Investment Corporation
April 2023
Req # A 2022_0014
All communications between lobbyist Gregory Lubar and staff within the Canada Development Investment Corporation from Oct. 1 2022 to the present dateOrganization: Canada Development Investment Corporation
April 2023
Req # A 2022_0015
All communications between lobbyist Alex Leath and staff within the Canada Development Investment Corporation from Oct. 1 2022 to the present dateOrganization: Canada Development Investment Corporation
April 2023